Cited by — Oral delivery of recombinant Lactococcus lactis expressing an IL-23 inhibitor as a potential therapeutic strategy for experimental colitis | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Oral delivery of recombinant Lactococcus lactis expressing an IL-23 inhibitor as a potential therapeutic strategy for experimental colitis.
No admitted local citation edges point to this work yet.
